Original Research
Accepted on 06 Jan 2025
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin.
in Alloimmunity and Transplantation
Original Research
Accepted on 06 Jan 2025
in Alloimmunity and Transplantation
Review
Accepted on 06 Jan 2025
in Nutrition Methodology
Original Research
Accepted on 06 Jan 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 06 Jan 2025
in Medicinal and Pharmaceutical Chemistry
Original Research
Accepted on 06 Jan 2025
in Leadership in Education
Original Research
Accepted on 06 Jan 2025
in Industrial Informatics
Original Research
Accepted on 06 Jan 2025
in Aging and Public Health
Review
Accepted on 06 Jan 2025
in Gastroenterology
Original Research
Accepted on 06 Jan 2025
in Alloimmunity and Transplantation
Brief Research Report
Accepted on 06 Jan 2025
in Thoracic Oncology
Original Research
Accepted on 06 Jan 2025
in Cryospheric Sciences
Original Research
Accepted on 06 Jan 2025
in Microbial Physiology and Metabolism
Systematic Review
Accepted on 06 Jan 2025
in Ethnopharmacology
Review
Accepted on 06 Jan 2025
in Microbial Immunology
Original Research
Accepted on 06 Jan 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 06 Jan 2025
in Cardiovascular Imaging